Patient-reported outcomes (PROs) are used in clinical trials to provide evidence of the
benefits and risks of interventions from a patient perspective and to inform regulatory …

Summary Patient-reported outcomes (PROs), such as symptoms, function, and other health-
related quality-of-life aspects, are increasingly evaluated in cancer randomised controlled …

Patient-reported outcomes (PROs) are used in clinical trials to provide valuable evidence on
the impact of disease and treatment on patients' symptoms, function and quality of life. High …

Abstract Background Patient-reported outcomes (PROs) are commonly collected in clinical
trials and should provide impactful evidence on the effect of interventions on patient …

The extent to which patient-reported outcome measures (PROMs) are used in clinical trials
for artificial intelligence (AI) technologies is unknown. In this systematic evaluation, we aim …

Importance Patient-reported outcomes (PROs) can inform health care decisions, regulatory
decisions, and health care policy. They also can be used for audit/benchmarking and …

Important breakthroughs in medical treatments have improved outcomes for patients
suffering from several types of cancer. However, many oncological treatments approved by …

Objectives In our systematic review, we assessed past and current practice of patient-
reported outcome (PRO) measurement in cancer randomized, controlled trials (RCTs) …

Clinical trials represent a fulcrum for oncology drug discovery and development to bring safe
and effective medicines to patients in a timely manner. Clinical trials have shifted from …

Summary In 2011, the International Society of Geriatric Oncology (SIOG) published the SIOG
10 Priorities Initiative, which defined top priorities for the improvement of the care of older …